You should confirm eligibility with your specific FSA/HSA administrator
that studied the effects of GLP-1 receptor agonists on neurological complications of diabetes (stroke, cognitive impairment, and peripheral neuropathy) showed that GLP-1 receptor agonists provide neuroprotection through anti-inflammatory, antioxidant, and antiapoptotic mechanisms
Preventive Services Task Force (USPSTF), the American Heart Association/American College of Cardiology/The Obesity Society (AHA/ACC/TOS), and the European Association for the Study of Obesity (EASO) each recommend multicomponent interventionsincluding caloric targets, physical activity, goal-setting, self-monitoring, and problem-solvingover a duration of at least six months to achieve clinically meaningful weight loss [35,36,37]
Abstract Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells